로그인

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.

Such synergistic combinations of antibiotics help reduce the minimum inhibitory concentration (MIC) of each by four-fold or more. Synergistic combinations of antibiotics are useful when an infectious agent is unknown or when pathogens have populations of varying drug sensitivity, such as Mycobacterium tuberculosis.

Combining trimethoprim and sulfamethoxazole represents one of the most effective treatments for urinary tract infections. This combination works by inhibiting the activity of two different enzymes involved in the folate pathway, which block the synthesis of purines, the building blocks of DNA. The unavailability of purines impedes DNA synthesis, which ultimately kills the bacteria. Other antibiotic combinations use cell wall-active drugs, such as penicillins, which enhance the permeability of drugs, combined with aminoglycosides, which act on intracellular targets, like 30S ribosomes. These combinations prove highly effective in treating such infections as bacterial endocarditis caused by Enterococcal endocarditis.

In addition, some drugs do not have their own effects but potentiate the effect of other drugs in combination. One useful interaction is between β-lactamase inhibitors such as clavulanic acid and β-lactamase susceptible penicillins. Antibiotics such as penicillins and cephalosporins have β-lactam rings. The bacterial β-lactamase enzyme hydrolyses these rings, making these drugs inactive and leading to the emergence of antibiotic resistance. Using β-lactamase inhibitors and such antibiotics helps overcome the resistance that these bacterial enzymes generate.

Tags
SynergismSupra additive InteractionsTherapeutic EffectDrug CombinationsMinimum Inhibitory Concentration MICTrimethoprimSulfamethoxazoleUrinary Tract InfectionsFolate PathwayDNA SynthesisPenicillinsAminoglycosidesBacterial EndocarditisClavulanic AcidAntibiotic Resistance

장에서 4:

article

Now Playing

4.15 : Combined Effects of Drugs: Synergism

Pharmacodynamics

3.0K Views

article

4.1 : 약물 작용의 원칙

Pharmacodynamics

5.4K Views

article

4.2 : 약물 작용의 목표: 개요

Pharmacodynamics

5.2K Views

article

4.3 : 신호 전달: 개요

Pharmacodynamics

8.0K Views

article

4.4 : 변환기 메커니즘: G 단백질 결합 수용체

Pharmacodynamics

1.6K Views

article

4.5 : 리간드 게이트 이온 채널 수용체: 게이팅 메커니즘

Pharmacodynamics

1.9K Views

article

4.6 : 변환기 메커니즘: 효소 결합 수용체

Pharmacodynamics

2.2K Views

article

4.7 : 트랜스듀서 메커니즘: 핵 수용체

Pharmacodynamics

1.2K Views

article

4.8 : 용량-반응 관계: 개요

Pharmacodynamics

2.7K Views

article

4.9 : 용량-반응 관계: 효능 및 효능

Pharmacodynamics

3.9K Views

article

4.10 : 용량-반응 관계: 선택성 및 특이성

Pharmacodynamics

6.1K Views

article

4.11 : 치료 지수

Pharmacodynamics

3.8K Views

article

4.12 : 약물-수용체 상호작용: 작용제

Pharmacodynamics

2.2K Views

article

4.13 : 약물-수용체 상호 작용: 길항제

Pharmacodynamics

2.4K Views

article

4.14 : 약물의 복합 효과: 길항작용

Pharmacodynamics

7.5K Views

See More

JoVE Logo

개인 정보 보호

이용 약관

정책

연구

교육

JoVE 소개

Copyright © 2025 MyJoVE Corporation. 판권 소유